Accelerating Long-Read NGS for Gene Therapy with Genedata Selector
Advancing NGS-Based Workflows in Biopharma Development
Alison Waterfield October 2, 2026
RNA Therapeutics at Scale: Why Data Strategy Now Defines Success
Fiona Siebrits October 1, 2026
Automating LC-Based N-Glycan Analysis for CMC
Development of NGS–Based Workflows for CQAs for Product Characterization in CGT
From Science to Compliance: Building Trusted NGS-Based GMP Assays
Genedata Selector: Accelerate the Path to GxP for Sequencing-Based Assays
An AI-Enabling Digital Infrastructure for NGS from Discovery to Manufacturing
A Blueprint for GMP-Compliant Generative AI
Valentina Armiento September 21, 2026
AI-Guided Discovery of Blood-Based Biomarkers for Alzheimer’s Disease
Nanobody Discovery with NGS: From Dominant Clones to Repertoire-Level Insight
Craig Blyth September 18, 2026
From NGS Data to Scalable Antibody and Nanobody Development Workflows
How Translational Research Data Analysis Empowers Interdisciplinary Teams in Precision Medicine
Fiona Siebrits September 17, 2026
Accelerating Preparative Chromatography Workflows Through Smarter Data Analysis
Analytical Chromatography Workflow Automation at Novartis
HILIC MS-enabled sMAM: Advancing the Future of Biotherapeutic Characterization
Structured Knowledge Management Platform for Bioprocess Development
Simplifying Deep Antibody Mining for Maximum Impact
Subunit-level mass spectrometry ADC Characterization
Mass Spectrometry QC Release Method Development
Novartis Reimagines CMC
The Value of Digital CMC
Genedata Vico
NGS-Based CQA Assessment with AI-Ready and GMP-Compliant Digital Infrastructure
Making NGS Work for Analytical Development and QC
Justyna Lisowska August 25, 2026
Qualification and Implementation of a Robust MAM Platform Across Multiple Labs
MDPI August 24, 2026
End-to-End Mass Spectrometry with Genedata
Data Integrity: ALCOA++ with Genedata
Identifying NGNA Sialylation in Antibodies with NGS
Craig Blyth August 5, 2026
Navigating Data Challenges in RNA Therapeutics: From Complexity to Clarity
Ming Wang August 3, 2026
Why AI Alone Will Not Solve Oligonucleotide Discovery
Justyna Lisowska, Ming Wang July 14, 2026
Genedata Biopharma Platform: Validation Support
AI Agents: From Automation to Augmented Intelligence
Justyna Lisowska July 9, 2026
TIDES 2026: Oligonucleotide Discovery is Moving to ‘The Beach’
Ming Wang July 7, 2026
Adventitious Viral Detection in Biologics Manufacturing
Alison Waterfield July 7, 2026
Implementing NGS‑Based Assays in GxP Environments
Valentina Armiento July 7, 2026
Designing Next-Gen Bioprocesses
Enabling NGS for Product Characterization and Biosafety in GxP
Valentina Armiento July 1, 2026
Driving Biopharma Automation and AI
Merck: Digitally Transforming Drug Discovery with Automated Data Workflows
